Close

Single Domain Antibody And scFv Affinity Improvement

Creative Biolabs has built a novel single domain antibody and scFv affinity improvement platform using our exclusive HIAF-ProNano™ affinity improvement technology. HIAF-ProNano™ can improve the target binding affinity of single domain antibodies and scFvs substantially by engaging of protein nanocages without changing any of the physico-chemical characteristics of single domain antibodies and scFvs. Great success has been made in improving the binding affinity of single domain antibody and scFv using our HIAF-ProNano™ platform, which infuses the features of protein nanocage with single domain antibodies and scFvs.

 Fig. 1 Schoonen and van Hest (2014).

Characteristics of HIAF-ProNanotTM
• Outstanding affinity improvement capability
• Remarkable homogeneity
• Extraordinary biocompatibility
• Self-assembling and flexible targeting ability
• Highly reproductive targeting operation
• Adjustable molecular level operation
• Multi-functionality

For questions and more information, please contact us at info@creative-biolabs.com

Reference

  1. Schoonen, L. and van Hest, J. C. (2014) 'Functionalization of protein-based nanocages for drug delivery applications', Nanoscale, 6(13), 7124-7141.

All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

USA:
Europe: UK - Germany
Call us at:
USA:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us